José Luis Ferreiro: After Stent Treatment in Heart Attack Patients How to Balance Bleeding and Clotting Risk
José Luis Ferreiro, Head of the Department of Cardiology at Hospital Universitari Joan XXIII, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Happy to share this new Clinical Consensus Statement led by the ESC Working Group on Thrombosis in collaboration with ACCA, EAPCI and Working Group on Cardiovascular Pharmacotherapy
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention
Discussing alternative antithrombotic strategies to standard DAPT to reduce bleeding (DAPT abbreviation and de-escalation) or ischaemic (prolonged DAT) risk and some guidance to individualize therapy.”
Erik Lerkevang Grove, Cardiologist at Aarhus University Hospital, Skejby shared this post on LinkedIn, adding:
”Proud to be part of this important and comprehensive consensus document:
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention.”
Title: Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks: A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
Authors: Diana A Gorog, Jurrien M ten Berg, Gianluca Campo, Tobias Geisler, Bruna Gigante, Erik L Grove, Sigrun Halvorsen, Kurt Huber, Young-Hoon Jeong, Gregory Y H Lip, Eliano P Navarese, Andrea Rubboli, Jolanta M Siller Matula, Robert F Storey, Marco Valgimigli, Christophe Vandenbriele, Gemma Vilahur, Ingo Ahrens, Jose Luis Ferreiro
Read the Full Article on European Heart Journal Acute Cardiovascular Care
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 01:15Tom Lazenby: Accelerating Rare Disease Drug Development Through MHRA’s Investigational Marketing Authorisation
-
May 25, 2026, 22:15Cedric Hermans: What Is Still To Be Discovered and To Be Redefined in The Treatment of Haemophilia A?
-
May 25, 2026, 16:27Gashaw Arega: Advancing Bleeding Disorders Care in Africa
-
May 25, 2026, 16:20Ai Phi Thuy Ho: Varicose Veins Show How Blood Flow Inside the Body Affects What You See on the Skin
-
May 25, 2026, 16:11Ashraf Ali Alsmadi: Recognizing the Difference Between Air Embolism and Pulmonary Embolism
-
May 25, 2026, 16:07Jeanett Mphume: Lymphedema and the Importance of Early Diagnosis
-
May 25, 2026, 15:53Nicolas Nesseler: Do We Overlook Factor XIII Deficiency in VA-ECMO Patients?
-
May 25, 2026, 15:47Wadha Al-Muftah: WHO Adopts Landmark Resolution on Precision Medicine
-
May 25, 2026, 15:43Robert Brown: Evidence-Based Management of Obstetric Hemorrhage